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Sun-Lin Huanga, Yu-Tsung Choub, Yu-Chia Hsieha,b, Yhu-Chering Huanga,b, 
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aDivision of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Children’s Hospital, Taoyuan, Taiwan.
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BACKGROUND/PURPOSE: There have been many reported cases of Listeria monocytogenes bacteremia 
in Europe and the United States, but only a few from Taiwan. The present study was undertaken to ana-
lyze the clinical characteristics of patients with L. monocytogenes bacteremia in Taiwan.
METHODS: Patients with culture-confirmed L. monocytogenes bacteremia were identified at Chang Gung 
Memorial Hospital between January 2001 and December 2008. The clinical features and outcomes of the 
patients and the antimicrobial susceptibilities of the clinical isolates were analyzed.
RESULTS: Forty-three patients, including two newborn babies (4.7%) and 41 adults (95.3%), with at least 
one episode of Listeria bacteremia were identified. Forty-two (97.7%) of these patients had underlying 
diseases. Thirty-three patients (76.7%) had fever, 14 (32.6%) had experienced respiratory distress, and 
11 (25.6%) had reported changes in consciousness. Twelve patients died within 14 days of infection, 
corresponding to a case-fatality rate of 27.9%. All the clinical isolates tested were susceptible to ampicillin, 
penicillin and vancomycin.
CONCLUSION: Most cases of L. monocytogenes infection occurred in adults with underlying diseases, 
especially malignancy, and only two cases of neonatal L. monocytogenes bacteremia were identified over the 
8-year period. Penicillin, ampicillin and vancomycin could be used for the treatment of L. monocytogenes 
bacteremia, with the case-fatality rate lower for patients who received appropriate treatment.
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Introduction
Listeria monocytogenes is an aerobic and facultatively anae-
robic, motile, Gram-positive rod that infects humans. 
Listeria infection is an uncommon disease in the general 
population, usually causing self-limited febrile gastroen-
teritis in previously healthy individuals who ingest high 
numbers of Listeria. However, L. monocytogenes infection 
can cause death in specific groups, including elderly 
adults, pregnant women, neonates and immunocompro-
mised patients. In these hosts, listeria infection may develop 
into sepsis or central nervous system infection (meningitis 
or meningoencephalitis).1–3
Although there have been several reports from Europe 
and the United States on the clinical manifestations of Listeria 
bacteremia,4–6 only one report has come from Taiwan.7 
Therefore, we reviewed the medical records of 43 patients 
with L. monocytogenes bacteremia at Chang Gung Memorial 
Hospital (CGMH) from 2001 to 2008. The goal of the 
present study was to analyze the clinical manifestations of 
patients with L. monocytogenes bacteremia in a medical center 
from Taiwan.
Methods
Patients and bacterial isolates
Patients with L. monocytogenes bacteremia were identified 
retrospectively from blood culture reports received from the 
clinical microbiology laboratory at CGMH from January 
2001 to December 2008. All the medical records of patients 
with blood cultures that grew L. monocytogenes were studied 
retrospectively. For this cohort, we reviewed the underlying 
host conditions (age, underlying diseases and immuno-
suppressed status), laboratory data [hemogram, C-reactive 
protein (CRP), cerebrospinal fluid (CSF) analyses, and anti-
microbial susceptibilities], clinical presentations, treat-
ments and outcomes.
We classified the patients into groups based on age 
and time of onset, to identify the age and year distribu-
tions of listeria infection, and compared the fatality rates 
of the groups. The clinical symptoms and signs, including 
fever, respiratory distress and consciousness changes, were 
recorded. Infections were considered nosocomial if they 
first appeared 48 hours or more after hospital admission or 
within 30 days after discharge.8 Antimicrobial susceptibility 
of the L. monocytogenes isolates from the patients was 
reviewed. The susceptibilities of the bacterial isolates to 
ampicillin, penicillin and vancomycin were determined by 
the E-test (AB Biodisk, Solna, Sweden), and the results 
were interpreted according to Clinical and Laboratory 
Standards Institute guidelines.9 We reviewed the treat-
ment course administered to each patient, to determine 
whether the patient received appropriate antibiotic therapy 
and the post-treatment outcomes were analyzed.
Identification
Simplified identification of L. monocytogenes was based on 
the following tests: Gram staining, observation of trem-
bling motility in a wet mount, positive catalase reaction, and 
esculin hydrolysis. L. monocytogenes is Gram-positive and 
rod-shaped, usually non-motile and catalase negative. The 
CAMP test uses a β-lysin-producing Staphylococcus aureus 
strain streaked in one direction on a sheep blood agar plate 
and test cultures of L. monocytogenes streaked at right angles 
(but not touching) the S. aureus culture streaks. An identi-
cal broth culture incubated at 37°C shows considerably 
less motility. This motility pattern is also illustrated by an 
“umbrella-shaped” pattern that develops after overnight 
incubation at room temperature of an agar stab culture.10
Definitions
An episode of significant bacteremia was defined as one or 
more L. monocytogenes-positive blood cultures, in combina-
tion with clinical sepsis. A case was considered maternal/
neonatal when a pregnant woman, a miscarriage, a stillbirth, 
or a newborn of less than 1 month of age was involved.11 
Meningitis was defined by the growth of L. monocytogenes 
in the CSF, elevated CSF protein (> 45 mg/dL) or pleocytosis 
(white blood cells > 100 cells/μL in CSF) with L. monocytogenes 
sepsis.12 Sepsis was defined as a positive blood culture 
sample with systemic inflammatory response syndrome.13 
Leukocytosis was defined by a white blood cell count greater 
than 10,000 cells/μL in the peripheral blood. Neutrophilia 
was defined as an absolute neutrophil count greater than 
7,500/μL in the peripheral blood, and neutropenia was 
defined as an absolute neutrophil count of less than 500/
μL.14 Fatality was defined as death within 14 days of a 
blood culture showing listeria infection. Appropriate treat-
ment was defined as therapy with ampicillin, penicillin, 
vancomycin, macrolides (erythromycin or azithromycin), 
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imipenem, meropenem, linezolid, teicoplanin or rifampin.15 
Gentamicin was considered to have a synergistic effect 
and cephalosporins were considered to be ineffective in 
these patients.15
Statistical analysis
Categorical variables were analyzed by Fisher’s exact test. 
Continuous variables were analyzed by Student’s t test. 
A p value less than 0.05 was considered statistically signif-
icant. Statistic analysis was performed using SPSS version 
15 (SPSS Inc., Chicago, IL, USA).
Results
Demographic data
Forty-three patients with at least one episode of L. monocy-
togenes bacteremia were identified at CGMH between 
January 2001 and December 2008, and were assigned to 
the following age groups: neonates (n = 2); 6–18 years 
(n = 1); 19–50 years (n = 9, 20.9%); 51–60 years (n = 13, 30.2%); 
61–70 years (n = 7, 16.3%); 71–80 years (n = 8, 18.6%); and 
81–90 years (n = 3, 7.0%) (Table 1). The ratio of males to 
females was 1.05 (22 vs. 21 patients). The numbers of years 
from onset of infection are shown in the Figure.
Diagnosis
For the 41 adult patients, 37 (90.2%) had a diagnosis of 
sepsis and 3 (7.3%) had meningitis and sepsis. Only one 
patient had pneumonia, with a chest X-ray showing left 
lower lobe pneumonia. The two neonatal patients suffered 
from listeriosis within 1 day of birth (early onset disease). 
However, one neonatal patient had meningitis and sepsis, 
while the other had sepsis only. The baby with a diagnosis 
of sepsis had a history of maternal fever.
Underlying diseases
All cases except one newborn patient had an underlying 
disease, such as solid tumors (n = 15, 34.9%), renal failure 
(n = 13, 30.2%), type II diabetes mellitus (n = 11, 25.6%). 
One neonatal patient was born prematurely with a gesta-
tion age of 29 weeks (Table 2).
Clinical symptoms, signs and outcomes
Thirty-three patients (76.7%) had fever, 14 (32.6%) had 
respiratory distress, 12 (27.9%) experienced consciousness 
Table 1. Age distribution of the 43 cases of Listeria monocytogenes 
infection
Age n (%) Case-fatality rate (%)
0–7 d 2 (4.7)  0
8 d to 3 mo 0 (0)  0
4 mo to 5 yr 0 (0)  0
6–18 yr 1 (2.3)  0
19–50 yr 9 (20.9) 11.1
51–60 yr 13 (30.2) 38.5
61–70 yr 7 (16.3) 42.8
71–80 yr 8 (18.6) 12.5
81–90 yr 3 (7.0) 66.7
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Figure. Numbers of cases of Listeria monocytogenes infection from 
2001 to 2008 diagnosed at Chang Gung Memorial Hospital, 
Taoyuan, Taiwan.
Table 2. Underlying conditions of the 43 patients with 
Listeria monocytogenes infection
Underlying diseases (n = 43) n (%)
Solid tumors 15 (34.9)
Renal failure 13 (30.2)
Type 2 diabetes mellitus 11 (25.6)
Lymphoid and hematopoietic malignancy 6 (14.0)
Systemic lupus erythematosus 4 (9.3)
Chronic hepatitis 3 (7.0)
Liver cirrhosis 3 (7.0)
Asthma under steroid treatment 2 (4.7)
Chronic obstructive pulmonary disease 2 (4.7)
Prematurity 1 (2.3)
Pregnancy 1 (2.3)
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changes, and six (13.9%) appeared lethargic. Twelve pa-
tients died within 14 days (fatality rate 27.9%). The high-
est case-fatality rate (66.7%) was noticed in patients aged 
80–90 years. There were no deaths among the two pediat-
ric patients (Table 1).
Antimicrobial susceptibilities and laboratory data
The blood isolates were tested for susceptibility to penicillin 
(n = 40), vancomycin (n = 14) and ampicillin (n = 10) (Table 3). 
Among the 43 patients, seven patients did not receive ap-
propriate treatment (ceftriaxone or cefazolin was used) 
and four patients died (57.1%). In contrast, 36 patients 
received at least one appropriate antibiotic, however eight 
patients (22.2%) subsequently died (p = 0.081).
Laboratory tests showed that 19 patients (46.3%) had 
leukocytosis, 18 (45.0%) had neutrophilia, and five had neu-
tropenia (11.6%). Thirteen (44.8%) of the 29 patients who 
received CRP testing had a CRP level greater than 100 mg/L.
Characteristics for fatal and surviving cases
Table 4 demonstrates the characteristics for fatal and sur-
viving cases. It would appear that people with type 2 dia-
betes mellitus or respiratory distress may have increased 
fatality rates in cases of L. monocytogenes bacteremia. 
Table 3. Minimum inhibitory concentrations of antibiotics against Listeria monocytogenes isolates
 MIC50 MIC90 Susceptible, n (%) Isolates tested, n
Penicillin 0.38 0.75 40 (100) 40
Vancomycin 0.50 1 14 (100) 14
Ampicillin 0.25 0.25 10 (100) 10
MIC = minimum inhibitory concentration.
Table 4. Characteristics between the fatal and survival casesa
 Fatality (n = 23) Survival (n = 31)  p
Agec 60.2 ± 14.5  52.2 ± 21.8 0.25
Sex   0.56b
 Female 5 (41.7)  16 (51.6)
 Male 7 (58.3)  15 (48.4)
 M:F 1.4 0.94
Underlying diseases
 Solid tumors 6 (50.0)  9 (29.0) 0.29
 Renal failure 4 (33.3)  10 (32.3) 1.00b
 Type 2 diabetes mellitus 1 (8.3) 10 (32.3) 0.14b
 Lymphoid and hematopoietic malignancy 1 (8.3)  5 (16.1) 0.66b
Clinical symptoms
 Fever 6 (50.0)  24 (77.4) 0.14b
 Respiratory distress 1 (8.3)  13 (41.9) 0.07b
 Consciousness change 3 (25.0)  9 (29.0) 1.00b
Laboratory data
 WBCc,d 8,133.3 ± 6,964.6  12,880.0 ± 14,367.3  0.28
 CRPc,e 139.0 ± 94.2 91.5 ± 95.5  0.26
aData presented as n (%) or mean ± standard deviation; bFisher’s exact test; cStudent’s t test; dnot all cases had white blood cell laboratory 
data available (fatal, n = 12; surviving, n = 30); dnot all cases had CRP laboratory data (fatal, n = 7; surviving, n = 23). CRP = C-reactive protein; 
F = female; M = male; WBC = white blood cell.
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However, both these factors did not show a statistically 
significant difference (p = 0.14 and p = 0.07). According to 
the definition, there were 22 cases (51.1%) of nosocomial 
infection and nine of the 22 cases (40.9%) died.
Discussion
The present study included only two neonatal patients 
(4.7%), both of whom were treated. A surveillance study in 
Spain (n = 40) comprised 32.5% newborn patients, and the 
mortality rate was as high as 61.5%.5 A study conducted in 
Israel (n = 1,149) showed 43% perinatal infections, and the 
perinatal patient case-fatality rate was up to 36%.16 However, 
the patient populations in the Spanish study and our present 
study are not sufficiently large to give statistically mean-
ingful results. The two newborns in the present study were 
cured, and it is reasonable to assume that almost all new-
born babies in Taiwan who have an unstable clinical con-
dition, such as fever, poor activity or poor appetite, receive 
empirical treatment with ampicillin and gentamicin. The 
two newborn babies in the present study received ampicillin 
and gentamicin after birth due to fever and respiratory 
distress. These two drugs generally show in vitro and in vivo 
activities against L. monocytogenes.9 According to a study at 
a national Taiwanese university,7 most neonatal cases 
with listeriosis also had respiratory distress (11/14) and 
half of the cases had involvement of the central nervous 
system, observations similar to those seen in our study.
In the present study, only three adult patients (7.3%) and 
one newborn baby (50%) were diagnosed with meningitis, 
with these percentages lower than the corresponding val-
ues from studies conducted in England (24%) and Israel 
(28%).16,17 The low rate of meningitis may be due to the 
low rate of CSF analysis in the present study. Only 11 
(25.6%) patients underwent a CSF survey; the rate of men-
ingitis might be increased if all the patients underwent 
this test.
All but one of the newborn patients had an underlying 
disease, and this rate was higher than those reported for 
studies conducted in England (75%) and Israel (74%).16,17 
Malignancy, diabetes mellitus and renal disease were also 
identified as risk factors in another country,16–18 whereas 
human immunodeficiency virus infection seems to be less 
common in Taiwan. Connective tissue disease, including sys-
temic lupus erythematosus, with previously accompanied 
listeriosis as either a comorbid or pre-existing condition, was 
noted in two case series and one outbreak.19 Viral hepatitis 
has also been linked to Listeria infection in case studies,20,21 
and systemic lupus erythematosus and viral hepatitis were 
implicated in the present study.
In the present study, the number of patients with liste-
riosis increased during the period from 2006 to 2008; this 
pattern of increased incidence was also noted in England 
and France,11,17 however the reason for the increase in 
incidence remains unclear. It may be linked to improve-
ments in laboratory methods (especially in the isolation 
of L. monocytogenes from blood samples) or changes in 
local clinical practices.
Historically, L. monocytogenes has been linked more 
often to infections among men than women,22 although 
this gap has narrowed in recent years, in agreement with our 
data. In the present study, all L. monocytogenes isolates showed 
in vitro susceptibility to nearly all the common antibiotics; 
similar to what has been reported previously.23 The optimal 
antimicrobial therapy for listeriosis has not been estab-
lished in controlled clinical trials. An overall mortality rate 
for L. monocytogenes bacteremia of 21–44% has been re-
ported,24,25 and our case-fatality rate of 27.9% falls within 
this range.
In conclusion, L. monocytogenes bacteremia in newborn 
babies is not common in Taiwan, but the recovery rate is 
high. L. monocytogenes bacteremia was diagnosed in immu-
nocompromised patients and elderly individuals, with 
ampicillin, penicillin and vancomycin found to be active 
against the L. monocytogenes isolates in the present study. 
Appropriate antibiotic treatment may decrease the 
L. monocytogenes bacteremia-related mortality rate.
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